Glusense AI

Curated by Signal

AI based platform offering solution for managing metabolic health

Overview

AI based platform offering solution for managing metabolic health. The flagship product is a biosensor designed to continuously monitor glucose levels, with the potential to diabetes management. The platform aims to simplify health management by offering personalized insights based on individual responses to various health factors such as diet and exercise.

Key facts

Founded: 2024
Headquarters: San Mateo, United States
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

DosedDaily
Provider of a learning app for doctors
Health TechnologyNew York City, United States
Agriplex Genomics
Tools for next-gen sequencing data analysis
Health TechnologyCleveland, United States
Amity
AI and cloud-based software for monitoring elders at care homes
Health TechnologyCookeville, United States

About Glusense AI

What does Glusense AI do?

AI based platform offering solution for managing metabolic health.

Where is Glusense AI headquartered?

Glusense AI is headquartered in San Mateo, United States.

When was Glusense AI founded?

Glusense AI was founded in 2024.

Which sector is Glusense AI in?

Glusense AI operates in Health Technology.

Who are Glusense AI's competitors?

Companies similar to Glusense AI include DosedDaily, Agriplex Genomics, and Amity.